{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:00:09Z","timestamp":1785297609443,"version":"3.55.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00281-017-0633-1","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T15:56:30Z","timestamp":1494863790000},"page":"343-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Cellular and molecular perspectives in rheumatoid arthritis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-4971","authenticated-orcid":false,"given":"Douglas J.","family":"Veale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Orr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Fearon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"633_CR1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","volume":"7","author":"IB McInnes","year":"2007","unstructured":"McInnes IB, Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7:429\u2013442","journal-title":"Nat Rev Immunol"},{"key":"633_CR2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/rheumatology\/XXXIV.suppl_4.74","volume":"34","author":"DM Heijde van der","year":"1995","unstructured":"van der Heijde DM (1995) Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol 34:74\u201378","journal-title":"Br J Rheumatol"},{"key":"633_CR3","doi-asserted-by":"crossref","unstructured":"Orr C et al (2017) Synovial immunophenotype and anti-citrullinated protein antibodies in rheumatoid arthritis patients: relationship to treatment response and radiological prognosis. Ann Rheum Dis","DOI":"10.1002\/art.40218"},{"key":"633_CR4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","volume":"71","author":"DM Gerlag","year":"2012","unstructured":"Gerlag DM et al (2012) EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the study group for risk factors for rheumatoid arthritis. Ann Rheum Dis 71:638\u2013641","journal-title":"Ann Rheum Dis"},{"key":"633_CR5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/ard.2010.139527","volume":"70","author":"MG Sande van de","year":"2011","unstructured":"van de Sande MG et al (2011) Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 70:772\u2013777","journal-title":"Ann Rheum Dis"},{"key":"633_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MMJ Nielen","year":"2004","unstructured":"Nielen MMJ et al (2004) Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 50:380\u2013386. doi: 10.1002\/art.20018","journal-title":"Arthritis Rheum"},{"key":"633_CR7","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741\u20132749","journal-title":"Arthritis Rheum"},{"key":"633_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/art.38273","volume":"66","author":"MJ Hair de","year":"2014","unstructured":"de Hair MJ et al (2014) Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol 66:513\u2013522. doi: 10.1002\/art.38273","journal-title":"Arthritis Rheumatol"},{"key":"633_CR9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","volume":"69","author":"WH Bos","year":"2010","unstructured":"Bos WH et al (2010) Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann Rheum Dis 69:490\u2013494","journal-title":"Ann Rheum Dis"},{"key":"633_CR10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-124-8-199604150-00001","volume":"124","author":"A Heide van der","year":"1996","unstructured":"van der Heide A et al (1996) The effectiveness of early treatment with \u201csecond-line\u201d antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 124:699\u2013707","journal-title":"Ann Intern Med"},{"key":"633_CR11","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0002-9343(01)00872-5","volume":"111","author":"LR Lard","year":"2001","unstructured":"Lard LR et al (2001) Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 111:446\u2013451","journal-title":"Am J Med"},{"key":"633_CR12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","volume":"43","author":"VPK Nell","year":"2004","unstructured":"Nell VPK et al (2004) Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 43:906\u2013914","journal-title":"Rheumatology"},{"key":"633_CR13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS et al (2010) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheumatic Dis 69:964\u2013975","journal-title":"Ann Rheumatic Dis"},{"key":"633_CR14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1136\/ard.59.12.945","volume":"59","author":"D Baeten","year":"2000","unstructured":"Baeten D et al (2000) Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis 59:945\u2013953","journal-title":"Ann Rheum Dis"},{"key":"633_CR15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1006\/clin.1995.1149","volume":"77","author":"PP Tak","year":"1995","unstructured":"Tak PP et al (1995) Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol 77:236\u2013242","journal-title":"Clin Immunol Immunopathol"},{"key":"633_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/clin.1998.4525","volume":"88","author":"TJ Smeets","year":"1998","unstructured":"Smeets TJ et al (1998) Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue. Clin Immunol Immunopathol 88:84\u201390","journal-title":"Clin Immunol Immunopathol"},{"key":"633_CR17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/annrheumdis-2014-206921","volume":"75","author":"L Yeo","year":"2016","unstructured":"Yeo L et al (2016) Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis. Ann Rheum Dis 75:763\u2013771","journal-title":"Ann Rheum Dis"},{"key":"633_CR18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/annrheumdis-2011-200612","volume":"71","author":"PL Klarenbeek","year":"2012","unstructured":"Klarenbeek PL et al (2012) Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease. Ann Rheum Dis 71:1088\u20131093","journal-title":"Ann Rheum Dis"},{"key":"633_CR19","doi-asserted-by":"crossref","first-page":"R784","DOI":"10.1186\/ar1733","volume":"7","author":"K Raza","year":"2005","unstructured":"Raza K et al (2005) Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 7:R784\u2013R795","journal-title":"Arthritis Res Ther"},{"key":"633_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0049-0172(79)80005-0","volume":"8","author":"ER Hurd","year":"1979","unstructured":"Hurd ER (1979) Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum 8:151\u2013176","journal-title":"Semin Arthritis Rheum"},{"key":"633_CR21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/PL00006853","volume":"19","author":"MA Cimmino","year":"2000","unstructured":"Cimmino MA et al (2000) Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 19:213\u2013217","journal-title":"Rheumatol Int"},{"key":"633_CR22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2008.096487","volume":"69","author":"D Sugiyama","year":"2010","unstructured":"Sugiyama D et al (2010) Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 69:70\u201381","journal-title":"Ann Rheum Dis"},{"key":"633_CR23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/ard.62.9.835","volume":"62","author":"P Stolt","year":"2003","unstructured":"Stolt P et al (2003) Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 62:835\u2013841","journal-title":"Ann Rheum Dis"},{"key":"633_CR24","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/ar4498","volume":"16","author":"D Di Giuseppe","year":"2014","unstructured":"Di Giuseppe D et al (2014) Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis. Arthritis Res Ther 16:R61","journal-title":"Arthritis Res Ther"},{"key":"633_CR25","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","volume":"50","author":"L Padyukov","year":"2004","unstructured":"Padyukov L et al (2004) A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 50:3085\u20133092","journal-title":"Arthritis Rheum"},{"key":"633_CR26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ncprheum0249","volume":"2","author":"L Klareskog","year":"2006","unstructured":"Klareskog L et al (2006) Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Clin Pract Rheumatol 2:425\u2013433","journal-title":"Nat Clin Pract Rheumatol"},{"key":"633_CR27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.130074","volume":"41","author":"B Lu","year":"2014","unstructured":"Lu B et al (2014) Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis. J Rheumatol 41:24\u201330","journal-title":"J Rheumatol"},{"key":"633_CR28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/ard.56.8.463","volume":"56","author":"KG Saag","year":"1997","unstructured":"Saag KG et al (1997) Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 56:463\u2013469","journal-title":"Ann Rheum Dis"},{"key":"633_CR29","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1093\/rheumatology\/39.11.1202","volume":"39","author":"B Masdottir","year":"2000","unstructured":"Masdottir B et al (2000) Smoking, rheumatoid factor isotypes and severity of rheumatoid arthritis. Rheumatology (Oxford) 39:1202\u20131205","journal-title":"Rheumatology (Oxford)"},{"key":"633_CR30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11926-016-0575-y","volume":"18","author":"SK Tedeschi","year":"2016","unstructured":"Tedeschi SK, Costenbader KH (2016) Is there a role for diet in the therapy of rheumatoid arthritis? Curr Rheumatol Rep 18:23","journal-title":"Curr Rheumatol Rep"},{"key":"633_CR31","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","volume":"10","author":"A Naranjo","year":"2008","unstructured":"Naranjo A et al (2008) Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 10:R30","journal-title":"Arthritis Res Ther"},{"key":"633_CR32","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/rheumatology\/kel124","volume":"45","author":"DJ Armstrong","year":"2006","unstructured":"Armstrong DJ et al (2006) Obesity and cardiovascular risk factors in rheumatoid arthritis. Rheumatology (Oxford) 45:782","journal-title":"Rheumatology (Oxford)"},{"key":"633_CR33","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1093\/rheumatology\/keq202","volume":"49","author":"JR Maxwell","year":"2010","unstructured":"Maxwell JR et al (2010) Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology (Oxford) 49:2140\u20132146","journal-title":"Rheumatology (Oxford)"},{"key":"633_CR34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2007.086314","volume":"68","author":"H K\u00e4llberg","year":"2009","unstructured":"K\u00e4llberg H et al (2009) Alcohol consumption is associated with decreased risk of rheumatoid arthritis: results from two Scandinavian case-control studies. Ann Rheumatic Dis 68:222\u2013227","journal-title":"Ann Rheumatic Dis"},{"key":"633_CR35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/rheumatology\/kes376","volume":"52","author":"IC Scott","year":"2013","unstructured":"Scott IC et al (2013) The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52:856\u2013867","journal-title":"Rheumatology (Oxford)"},{"key":"633_CR36","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1073\/pnas.0608620104","volume":"104","author":"IM Jonsson","year":"2007","unstructured":"Jonsson IM et al (2007) Ethanol prevents development of destructive arthritis. Proc Natl Acad Sci U S A 104:258\u2013263","journal-title":"Proc Natl Acad Sci U S A"},{"key":"633_CR37","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.4049\/jimmunol.156.8.2761","volume":"156","author":"CJ Krco","year":"1996","unstructured":"Krco CJ et al (1996) Characterization of the antigenic structure of human type II collagen. J Immunol 156:2761\u20132768","journal-title":"J Immunol"},{"key":"633_CR38","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1172\/JCI119348","volume":"99","author":"I Auger","year":"1997","unstructured":"Auger I, Roudier J (1997) A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK. Implications for the association of rheumatoid arthritis with HLA-DR4. J Clin Invest 99:1818\u20131822","journal-title":"J Clin Invest"},{"key":"633_CR39","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.27552","volume":"62","author":"N Wegner","year":"2010","unstructured":"Wegner N et al (2010) Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 62:2662\u20132672","journal-title":"Arthritis Rheum"},{"key":"633_CR40","first-page":"1442","volume":"17","author":"T Kouri","year":"1990","unstructured":"Kouri T et al (1990) Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera. J Rheumatol 17:1442\u20131449","journal-title":"J Rheumatol"},{"key":"633_CR41","first-page":"866","volume":"27","author":"S Blaschke","year":"2000","unstructured":"Blaschke S et al (2000) Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis. J Rheumatol 27:866\u2013873","journal-title":"J Rheumatol"},{"key":"633_CR42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(85)90352-6","volume":"2","author":"A Ebringer","year":"1985","unstructured":"Ebringer A et al (1985) Antibodies to proteus in rheumatoid arthritis. Lancet 2:305\u2013307","journal-title":"Lancet"},{"key":"633_CR43","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/1529-0131(200107)44:7<1582::AID-ART281>3.0.CO;2-E","volume":"44","author":"NB Ray","year":"2001","unstructured":"Ray NB et al (2001) Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts. Arthritis Rheum 44:1582\u20131586","journal-title":"Arthritis Rheum"},{"key":"633_CR44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00774-014-0575-9","volume":"33","author":"H Kanagawa","year":"2015","unstructured":"Kanagawa H et al (2015) Mycobacterium tuberculosis promotes arthritis development through Toll-like receptor 2. J Bone Miner Metab 33:135\u2013141","journal-title":"J Bone Miner Metab"},{"key":"633_CR45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/ard.2006.056937","volume":"66","author":"K Forslind","year":"2007","unstructured":"Forslind K et al (2007) Sex: a major predictor of remission in early rheumatoid arthritis? Ann Rheum Dis 66:46\u201352","journal-title":"Ann Rheum Dis"},{"key":"633_CR46","doi-asserted-by":"crossref","first-page":"II\/65","DOI":"10.1007\/s003930070021","volume":"59","author":"M Cutolo","year":"2000","unstructured":"Cutolo M et al (2000) The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. Z Rheumatol 59:II\/65\u2013II\/69","journal-title":"Z Rheumatol"},{"key":"633_CR47","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1196\/annals.1386.043","volume":"1089","author":"M Cutolo","year":"2006","unstructured":"Cutolo M et al (2006) Estrogens and autoimmune diseases. Ann N Y Acad Sci 1089:538\u2013547","journal-title":"Ann N Y Acad Sci"},{"key":"633_CR48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/rheumatology\/27.6.440","volume":"27","author":"D Gordon","year":"1988","unstructured":"Gordon D et al (1988) Prolonged hypogonadism in male patients with rheumatoid arthritis during flares in disease activity. Br J Rheumatol 27:440\u2013444","journal-title":"Br J Rheumatol"},{"key":"633_CR49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1196\/annals.1423.066","volume":"1110","author":"D Auci","year":"2007","unstructured":"Auci D et al (2007) A new orally bioavailable syntheic androstene inhibits collagen-induced arthritis in the mouse. Ann N Y Acad Sci 1110:630\u2013640","journal-title":"Ann N Y Acad Sci"},{"key":"633_CR50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00011-003-1244-y","volume":"53","author":"A R\u00f6ntzsch","year":"2004","unstructured":"R\u00f6ntzsch A et al (2004) Amelioration of murine antigen-induced arthritis by dehydroepiandrosterone (DHEA). Inflamm Research 53:189\u2013198","journal-title":"Inflamm Research"},{"key":"633_CR51","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/anr.1780321204","volume":"32","author":"W Hassfeld","year":"1989","unstructured":"Hassfeld W et al (1989) Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum 32:1515\u20131520","journal-title":"Arthritis Rheum"},{"key":"633_CR52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI119504","volume":"100","author":"K Skriner","year":"1997","unstructured":"Skriner K et al (1997) Anti-A2 \/ RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J Clin Invest 100:127\u2013135","journal-title":"J Clin Invest"},{"key":"633_CR53","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi J et al (2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Nat Acad Sci USA 108:17372\u201317377","journal-title":"Proc Nat Acad Sci USA"},{"key":"633_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"633_CR55","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S et al (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48:2741\u20132749","journal-title":"Arthritis Rheum"},{"key":"633_CR56","doi-asserted-by":"publisher","first-page":"R146","DOI":"10.1186\/ar2820. 63","volume":"11","author":"MD Mjaavatten","year":"2009","unstructured":"Mjaavatten MD et al (2009) Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort. Arthritis Res Ther 11:R146. doi: 10.1186\/ar2820. 63","journal-title":"Arthritis Res Ther"},{"key":"633_CR57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","volume":"46","author":"KP Machold","year":"2007","unstructured":"Machold KP et al (2007) Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford) 46:342\u2013349","journal-title":"Rheumatology (Oxford)"},{"key":"633_CR58","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","volume":"7","author":"AH Helm-van Mil van der","year":"2005","unstructured":"van der Helm-van Mil AH et al (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949\u2013R958","journal-title":"Arthritis Res Ther"},{"key":"633_CR59","first-page":"1691","volume":"30","author":"LM Jansen","year":"2003","unstructured":"Jansen LM et al (2003) The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis. J Rheumatol 30:1691\u20131695","journal-title":"J Rheumatol"},{"key":"633_CR60","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot EJ et al (2000) The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 43:1831\u20131835","journal-title":"Arthritis Rheum"},{"key":"633_CR61","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/ard.2006.068247","volume":"67","author":"SW Syversen","year":"2008","unstructured":"Syversen SW et al (2008) High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 67:212\u2013217","journal-title":"Ann Rheum Dis"},{"key":"633_CR62","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3899\/jrheum.101261","volume":"38","author":"F Aubart","year":"2011","unstructured":"Aubart F et al (2011) High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis. J Rheumatol 38:979\u2013982","journal-title":"J Rheumatol"},{"key":"633_CR63","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/annrheumdis-2015-208873","volume":"76","author":"LB Nordberg","year":"2017","unstructured":"Nordberg LB et al (2017) Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naive patients classified according to the 2010 ACR\/EULAR criteria. Ann Rheum Dis 76:341\u2013345","journal-title":"Ann Rheum Dis"},{"key":"633_CR64","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1600-0463.2007.apm_682a.x","volume":"115","author":"E Waaler","year":"2007","unstructured":"Waaler E (2007) On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles. 1939. APMIS\u00a0: acta pathologica, microbiologica, et immunologica Scandinavica 115:422\u2013438","journal-title":"APMIS\u00a0: acta pathologica, microbiologica, et immunologica Scandinavica"},{"key":"633_CR65","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0049-0172(76)90013-5","volume":"4","author":"AT Masi","year":"1976","unstructured":"Masi AT (1976) Prospective study of the early course of rheumatoid arthritis in young adults:comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome. Semin Arthritis Rheum 4:299\u2013326","journal-title":"Semin Arthritis Rheum"},{"key":"633_CR66","first-page":"782","volume":"16","author":"WC Shiel Jr","year":"1989","unstructured":"Shiel WC Jr, Jason M (1989) The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist. J Rheumatol 16:782\u2013785","journal-title":"J Rheumatol"},{"key":"633_CR67","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1996.00440120079007","volume":"156","author":"CA Slater","year":"1996","unstructured":"Slater CA et al (1996) Antinuclear antibody testing. A study of clinical utility. Arch Intern Med 156:1421\u20131425","journal-title":"Arch Intern Med"},{"key":"633_CR68","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/ard.62.4.303","volume":"62","author":"MD Smith","year":"2003","unstructured":"Smith MD et al (2003) Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints. Ann Rheum Dis 62:303\u2013307","journal-title":"Ann Rheum Dis"},{"key":"633_CR69","unstructured":"Firestein GS, Veale DJ (2016) Synovium. In: Kelley and Firestein\u2019s (ed) Textbook of rheumatology, 10th edn. Elsevier Health Sciences"},{"key":"633_CR70","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1172\/JCI200522263","volume":"115","author":"DK Rhee","year":"2005","unstructured":"Rhee DK et al (2005) The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 115:622\u2013631","journal-title":"J Clin Invest"},{"issue":"4","key":"633_CR71","first-page":"579","volume":"24","author":"A Hyc","year":"2009","unstructured":"Hyc A et al (2009) Pro-and anti-inflammatory cytokines increase hyaluronan production by rat synovial membrane in vitro. Int J Mol Med 24(4):579","journal-title":"Int J Mol Med"},{"key":"633_CR72","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1089\/ten.tea.2009.0210","volume":"16","author":"ME Blewis","year":"2009","unstructured":"Blewis ME et al (2009) Interactive cytokine regulation of synoviocyte lubricant secretion. Tissue Eng Part A 16:1329\u20131337","journal-title":"Tissue Eng Part A"},{"key":"633_CR73","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10408363.2013.802408","volume":"50","author":"D Cretu","year":"2013","unstructured":"Cretu D et al (2013) Delineating the synovial fluid proteome: recent advancements and ongoing challenges in biomarker research. Crit Rev Clin Lab Sci 50:51\u201363","journal-title":"Crit Rev Clin Lab Sci"},{"key":"633_CR74","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1089\/ars.2008.2400","volume":"11","author":"KM Oliver","year":"2009","unstructured":"Oliver KM et al (2009) Hypoxia activates NF-kappaB-dependent gene expression through the canonical signaling pathway. Antioxid Redox Signal 11:2057\u20132064","journal-title":"Antioxid Redox Signal"},{"key":"633_CR75","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/annrheumdis-2013-204105","volume":"74","author":"W Gao","year":"2015","unstructured":"Gao W et al (2015) Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis. Ann Rheum Dis 74:1275\u20131283","journal-title":"Ann Rheum Dis"},{"key":"633_CR76","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/ard.2004.022434","volume":"64","author":"I Tchetverikov","year":"2005","unstructured":"Tchetverikov I et al (2005) MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis 64:694\u2013698","journal-title":"Ann Rheum Dis"},{"key":"633_CR77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1749-6632.1999.tb07743.x","volume":"30","author":"U Fearon","year":"1999","unstructured":"Fearon U et al (1999) Synovial cytokine and growth factor regulation of MMPs\/TIMPs: implications for erosions and angiogenesis in early rheumatoid and psoriatic arthritis patients. Ann N Y Acad Sci 30:619\u2013621","journal-title":"Ann N Y Acad Sci"},{"key":"633_CR78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/art.1780400206","volume":"40","author":"PP Tak","year":"1997","unstructured":"Tak PP et al (1997) Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 40:217\u2013225","journal-title":"Arthritis Rheum"},{"key":"633_CR79","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/ard.2005.036905","volume":"65","author":"MD Smith","year":"2006","unstructured":"Smith MD et al (2006) Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go? Ann Rheum Dis 65:93\u2013100","journal-title":"Ann Rheum Dis"},{"key":"633_CR80","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/art.27287","volume":"62","author":"A Kennedy","year":"2010","unstructured":"Kennedy A et al (2010) Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 62:711\u2013721","journal-title":"Arthritis Rheum"},{"key":"633_CR81","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM199005033221805","volume":"322","author":"FH Epstein","year":"1990","unstructured":"Epstein FH, Harris ED Jr (1990) Rheumatoid arthritis: pathophysiology and implications for therapy. New Eng J Med 322:1277\u20131289","journal-title":"New Eng J Med"},{"key":"633_CR82","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI117753","volume":"95","author":"B M\u00e5nsson","year":"1995","unstructured":"M\u00e5nsson B et al (1995) Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 95:1071\u20131077","journal-title":"J Clin Invest"},{"key":"633_CR83","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/ard.2009.119776","volume":"69","author":"CT Ng","year":"2010","unstructured":"Ng CT et al (2010) Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis 69:1389\u20131395","journal-title":"Ann Rheum Dis"},{"key":"633_CR84","first-page":"260","volume":"30","author":"U Fearon","year":"2003","unstructured":"Fearon U et al (2003) Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 30:260\u2013268","journal-title":"J Rheumatol"},{"key":"633_CR85","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/1529-0131(200109)44:9<2024::AID-ART351>3.0.CO;2-K","volume":"44","author":"A Fraser","year":"2001","unstructured":"Fraser A et al (2001) Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum 44:2024\u20132028","journal-title":"Arthritis Rheum"},{"issue":"1","key":"633_CR86","doi-asserted-by":"publisher","first-page":"e82088","DOI":"10.1371\/journal.pone.0082088","volume":"9","author":"S Garc\u00eda","year":"2014","unstructured":"Garc\u00eda S et al (2014) Tie2 signaling cooperates with TNF to promote the pro-inflammatory activation of human macrophages independently of macrophage functional phenotype. PLoS One 9(1):e82088. doi: 10.1371\/journal.pone.0082088","journal-title":"PLoS One"},{"key":"633_CR87","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/annrheumdis-2011-200718","volume":"71","author":"S Krausz","year":"2012","unstructured":"Krausz S et al (2012) Angiopoietin-2 promotes inflammatory activation of human macrophages. Ann Rheum Dis 71:1402\u20131410","journal-title":"Ann Rheum Dis"},{"key":"633_CR88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrrheum.2016.69","volume":"12","author":"U Fearon","year":"2016","unstructured":"Fearon U et al (2016) Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nat Rev Rheumatol 12:385\u2013397","journal-title":"Nat Rev Rheumatol"},{"key":"633_CR89","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1002\/art.1780241215","volume":"24","author":"JR Levick","year":"1981","unstructured":"Levick JR (1981) Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum 24:1550\u20131560","journal-title":"Arthritis Rheum"},{"key":"633_CR90","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1136\/ard.44.12.817","volume":"44","author":"LB Dahl","year":"1985","unstructured":"Dahl LB et al (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44:817\u2013822","journal-title":"Ann Rheum Dis"},{"key":"633_CR91","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wsbm.157","volume":"4","author":"AY Hui","year":"2012","unstructured":"Hui AY et al (2012) A systems biology approach to synovial joint lubrication in health, injury, and disease. Wiley Interdiscip Rev Syst Biol Med 4:15\u201337","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"7","key":"633_CR92","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/1529-0131(199907)42:7<1481::AID-ANR23>3.0.CO;2-E","volume":"42","author":"RJ Reece","year":"1999","unstructured":"Reece RJ et al (1999) Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis. Arthritis & Rheumatism 42(7):1481\u20131484","journal-title":"Arthritis & Rheumatism"},{"issue":"12","key":"633_CR93","doi-asserted-by":"publisher","first-page":"e8131","DOI":"10.1371\/journal.pone.0008131","volume":"4","author":"E Izquierdo","year":"2009","unstructured":"Izquierdo E et al (2009) Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS One 4(12):e8131. doi: 10.1371\/journal.pone.0008131","journal-title":"PLoS One"},{"issue":"2","key":"633_CR94","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar4555","volume":"16","author":"G Dennis Jr","year":"2014","unstructured":"Dennis G Jr et al (2014) Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther 16(2):R90","journal-title":"Arthritis Res Ther"},{"key":"633_CR95","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/art.1780390116","volume":"39","author":"D Mulherin","year":"1996","unstructured":"Mulherin D et al (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39:115\u2013124","journal-title":"Arthritis Rheum"},{"key":"633_CR96","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd1109","volume":"2","author":"JS Smolen","year":"2003","unstructured":"Smolen JS, Steiner G (2003) Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Dis 2:473\u2013488","journal-title":"Nat Rev Drug Dis"},{"key":"633_CR97","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2004.029751","volume":"64","author":"JJ Haringman","year":"2005","unstructured":"Haringman JJ et al (2005) Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 64:834\u2013838","journal-title":"Ann Rheum Dis"},{"key":"633_CR98","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3899\/jrheum.090348","volume":"36","author":"B Bresnihan","year":"2009","unstructured":"Bresnihan B et al (2009) Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. J Rheumatol 36:1800\u20131802","journal-title":"J Rheumatol"},{"key":"633_CR99","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/BOR.0b013e32805e87ae","volume":"19","author":"Z Szekanecz","year":"2007","unstructured":"Szekanecz Z, Koch AE (2007) Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol 19:289\u2013295","journal-title":"Curr Opin Rheumatol"},{"key":"633_CR100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/ar115","volume":"2","author":"IB McInnes","year":"2000","unstructured":"McInnes IB et al (2000) Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells. Arthritis Res 2:374\u2013378","journal-title":"Arthritis Res"},{"issue":"Suppl 3","key":"633_CR101","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1186\/ar558","volume":"4","author":"D Burger","year":"2002","unstructured":"Burger D, Dayer J-M (2002) The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction. Arthritis Res 4(Suppl 3):S169\u2013S176","journal-title":"Arthritis Res"},{"key":"633_CR102","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/path.4466","volume":"235","author":"B Soler Palacios","year":"2015","unstructured":"Soler Palacios B et al (2015) Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile. J Pathol 235:515\u2013526","journal-title":"J Pathol"},{"key":"633_CR103","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1189\/jlb.1212627","volume":"95","author":"C Strehl","year":"2014","unstructured":"Strehl C et al (2014) Hypoxia: how does the monocyte-macrophage system respond to changes in oxygen availability? J Leukoc Biol 95:233\u2013241. doi: 10.1189\/jlb.1212627","journal-title":"J Leukoc Biol"},{"key":"633_CR104","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1172\/JCI112312","volume":"77","author":"T Iguchi","year":"1986","unstructured":"Iguchi T, Ziff M (1986) Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest 77:355\u2013361","journal-title":"J Clin Invest"},{"key":"633_CR105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/ard.2008.089284","volume":"68","author":"JD Ca\u00f1ete","year":"2009","unstructured":"Ca\u00f1ete JD et al (2009) Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann Rheum Dis 68:751\u2013756","journal-title":"Ann Rheum Dis"},{"key":"633_CR106","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/ard.62.5.472","volume":"62","author":"PA Klimiuk","year":"2003","unstructured":"Klimiuk PA et al (2003) Circulating tumour necrosis factor alpha and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis. Ann Rheum Dis 62:472\u2013475","journal-title":"Ann Rheum Dis"},{"key":"633_CR107","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P et al (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361:888\u2013898","journal-title":"N Engl J Med"},{"key":"633_CR108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/ar1478","volume":"7","author":"E Lubberts","year":"2005","unstructured":"Lubberts E et al (2005) The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7:29\u201337","journal-title":"Arthritis Res Ther"},{"key":"633_CR109","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4049\/jimmunol.1402990","volume":"195","author":"SA Basdeo","year":"2015","unstructured":"Basdeo SA et al (2015) Polyfunctional, pathogenic CD161+ Th17 lineage cells are resistant to regulatory T cell-mediated suppression in the context of autoimmunity. J Immunol 195:528\u2013540","journal-title":"J Immunol"},{"key":"633_CR110","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/art.1780390107","volume":"39","author":"EH Choy","year":"1996","unstructured":"Choy EH et al (1996) Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens. Arthritis Rheum 39:52\u201356","journal-title":"Arthritis Rheum"},{"key":"633_CR111","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/ard.58.6.342","volume":"58","author":"DJ Veale","year":"1999","unstructured":"Veale DJ et al (1999) Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology. Ann Rheum Dis 58:342\u2013349","journal-title":"Ann Rheum Dis"},{"key":"633_CR112","first-page":"220","volume":"29","author":"U Mason","year":"2002","unstructured":"Mason U et al (2002) CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis. J Rheumatol 29:220\u2013229","journal-title":"J Rheumatol"},{"key":"633_CR113","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","volume":"542","author":"DA Rao","year":"2017","unstructured":"Rao DA et al (2017) Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 542:110\u2013114","journal-title":"Nature"},{"key":"633_CR114","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(16)00380-9","volume":"388","author":"D Porter","year":"2016","unstructured":"Porter D et al (2016) Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial. Lancet 388:239\u2013247","journal-title":"Lancet"},{"key":"633_CR115","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1002\/art.22967","volume":"56","author":"YK Teng","year":"2007","unstructured":"Teng YK et al (2007) Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment. Arthritis Rheum 56:3909\u20133918","journal-title":"Arthritis Rheum"},{"issue":"1","key":"633_CR116","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1371\/journal.pmed.0060001","volume":"6","author":"F Humby","year":"2009","unstructured":"Humby F et al (2009) Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med 6(1):e1. doi: 10.1371\/journal.pmed.0060001","journal-title":"PLoS Med"},{"key":"633_CR117","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20121486","volume":"210","author":"K Amara","year":"2013","unstructured":"Amara K et al (2013) Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med 210:445\u2013455","journal-title":"J Exp Med"},{"key":"633_CR118","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1093\/rheumatology\/keu163","volume":"53","author":"S Bugatti","year":"2014","unstructured":"Bugatti S et al (2014) High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease. Rheumatology (Oxford) 53:1886\u20131895","journal-title":"Rheumatology (Oxford)"},{"key":"633_CR119","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2014-206598","volume":"75","author":"Y Rombouts","year":"2016","unstructured":"Rombouts Y et al (2016) Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis. Ann Rheum Dis 75:578\u2013585","journal-title":"Ann Rheum Dis"},{"key":"633_CR120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/path.1711390314","volume":"139","author":"HG Fassbender","year":"1983","unstructured":"Fassbender HG, Simmling-Annefeld M (1983) The potential aggressiveness of synovial tissue in rheumatoid arthritis. J Pathol 139:399\u2013406","journal-title":"J Pathol"},{"key":"633_CR121","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clim.2004.12.009","volume":"115","author":"A Mor","year":"2005","unstructured":"Mor A et al (2005) The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol 115:118\u2013128","journal-title":"Clin Immunol"},{"key":"633_CR122","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10495-009-0317-y","volume":"14","author":"A Korb","year":"2009","unstructured":"Korb A et al (2009) Cell death in rheumatoid arthritis. Apoptosis 14:447\u2013454. doi: 10.1007\/s10495-009-0317-y","journal-title":"Apoptosis"},{"key":"633_CR123","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0002-9440(10)64289-7","volume":"162","author":"CA Seemayer","year":"2003","unstructured":"Seemayer CA et al (2003) Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis. Am J Pathol 162:1549\u20131557","journal-title":"Am J Pathol"},{"key":"633_CR124","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.4049\/jimmunol.171.4.1732","volume":"171","author":"AN Vallejo","year":"2003","unstructured":"Vallejo AN et al (2003) Synoviocyte-mediated expansion of inflammatory T cells in rheumatoid synovitis is dependent on CD47-thrombospondin 1 interaction. J Immunol 171:1732\u20131740","journal-title":"J Immunol"},{"key":"633_CR125","first-page":"20","volume":"64","author":"AM Abeles","year":"2006","unstructured":"Abeles AM, Pillinger MH (2006) The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases. Bull NYU Hosp Jt Dis 64:20\u201324","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"633_CR126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.1780400104","volume":"40","author":"GR Burmester","year":"1997","unstructured":"Burmester GR et al (1997) Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum 40:5\u201318","journal-title":"Arthritis Rheum"},{"key":"633_CR127","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/art.21118","volume":"52","author":"TCA Tolboom","year":"2005","unstructured":"Tolboom TCA et al (2005) Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum 52:1999\u20132002","journal-title":"Arthritis Rheum"},{"key":"633_CR128","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell","year":"1994","unstructured":"Darnell JE et al (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415\u20131421","journal-title":"Science"},{"key":"633_CR129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","volume":"16","author":"WJ Leonard","year":"1998","unstructured":"Leonard WJ, O'Shea JJ (1998) Jaks and STATs: biological implications. Annu Rev Immunol 16:293\u2013322","journal-title":"Annu Rev Immunol"},{"key":"633_CR130","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","volume":"186","author":"K Ghoreschi","year":"2011","unstructured":"Ghoreschi K et al (2011) Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol 186:4234\u20134243","journal-title":"J Immunol"},{"key":"633_CR131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0140-6736(12)61424-X","volume":"381","author":"GR Burmester","year":"2013","unstructured":"Burmester GR (2013) Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial. Lancet 381:451\u2013460","journal-title":"Lancet"},{"key":"633_CR132","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/art.37816","volume":"65","author":"D Heijde van der","year":"2013","unstructured":"van der Heijde D et al (2013) Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study. Arthritis Rheum 65:559\u2013570","journal-title":"Arthritis Rheum"},{"key":"633_CR133","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00296-015-3291-4","volume":"35","author":"YH Lee","year":"2015","unstructured":"Lee YH et al (2015) Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Rheumatol Int 35:1965\u20131974","journal-title":"Rheumatol Int"},{"key":"633_CR134","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2014-206028","volume":"74","author":"DL Boyle","year":"2015","unstructured":"Boyle DL et al (2015) The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis. Ann Rheum Dis 74:1311\u20131316","journal-title":"Ann Rheum Dis"},{"key":"633_CR135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/art.11425","volume":"50","author":"JHW Distler","year":"2004","unstructured":"Distler JHW et al (2004) Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 50:10\u201323","journal-title":"Arthritis Rheum"},{"issue":"4","key":"633_CR136","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/annrheumdis-2011-200245","volume":"71","author":"LC Harty","year":"2012","unstructured":"Harty LC et al (2012) Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis. Ann Rheum Dis 71(4):582\u2013588","journal-title":"Ann Rheum Dis"},{"key":"633_CR137","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1756-185X.2011.01598.x","volume":"14","author":"X Chang","year":"2011","unstructured":"Chang X, Wei C (2011) Glycolysis and rheumatoid arthritis. Int J Rheum Dis 14:217\u2013222. doi: 10.1111\/j.1756-185X.2011.01598.x","journal-title":"Int J Rheum Dis"},{"key":"633_CR138","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/ard.38.1.63","volume":"38","author":"B Henderson","year":"1979","unstructured":"Henderson B et al (1979) Glycolytic activity in human synovial lining cells in rheumatoid arthritis. Ann Rheum Dis 38:63\u201367","journal-title":"Ann Rheum Dis"},{"key":"633_CR139","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1136\/annrheumdis-2015-208476","volume":"75","author":"M Biniecka","year":"2016","unstructured":"Biniecka M et al (2016) Dysregulated bioenergetics: a key regulator of joint inflammation. Ann Rheum Dis 75:2192\u20132200. doi: 10.1136\/annrheumdis-2015-208476","journal-title":"Ann Rheum Dis"},{"key":"633_CR140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/em.20554","volume":"51","author":"MC Frantz","year":"2010","unstructured":"Frantz MC, Wipf P (2010) Mitochondria as a target in treatment. Environ Mol Mutagen 51:462\u2013475","journal-title":"Environ Mol Mutagen"},{"key":"633_CR141","doi-asserted-by":"crossref","first-page":"364","DOI":"10.14336\/AD.2013.0400364","volume":"4","author":"SC Zapico","year":"2013","unstructured":"Zapico SC, Ubelaker DH (2013) mtDNA mutations and their role in aging, diseases and forensic sciences. Aging Dis 4:364\u2013380","journal-title":"Aging Dis"},{"key":"633_CR142","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/med.20117","volume":"28","author":"G Poli","year":"2008","unstructured":"Poli G et al (2008) 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 28:569\u2013631","journal-title":"Med Res Rev"},{"key":"633_CR143","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrg1606","volume":"6","author":"RW Taylor","year":"2005","unstructured":"Taylor RW, Turnbull DM (2005) Mitochondrial DNA mutations in human disease. Nat Rev Genet 6:389\u2013402","journal-title":"Nat Rev Genet"},{"key":"633_CR144","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/ar1809","volume":"7","author":"C Ospelt","year":"2005","unstructured":"Ospelt C, Gay S (2005) Somatic mutations in mitochondria: the chicken or the egg? Arthritis Res Ther 7:179\u2013180","journal-title":"Arthritis Res Ther"},{"key":"633_CR145","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/art.30395","volume":"63","author":"M Biniecka","year":"2011","unstructured":"Biniecka M et al (2011) Hypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis. Arthritis Rheum 63:2172\u20132182","journal-title":"Arthritis Rheum"},{"key":"633_CR146","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/ard.2009.111211","volume":"69","author":"M Biniecka","year":"2010","unstructured":"Biniecka M et al (2010) Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann Rheum Dis 69:1172\u20131178","journal-title":"Ann Rheum Dis"},{"key":"633_CR147","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM et al (2013) Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 496:238\u2013242","journal-title":"Nature"},{"key":"633_CR148","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1002\/art.38822","volume":"66","author":"M Biniecka","year":"2014","unstructured":"Biniecka M et al (2014) Redox-mediated angiogenesis in the hypoxic joint of inflammatory arthritis. Arthritis Rheumatol 66:3300\u20133310","journal-title":"Arthritis Rheumatol"},{"key":"633_CR149","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10067-013-2352-x","volume":"33","author":"B Szalay","year":"2014","unstructured":"Szalay B et al (2014) The impact of conventional DMARD and biological therapies on CD4+ cell subsets in rheumatoid arthritis: a follow-up study. Clin Rheumatol 33:175\u2013185","journal-title":"Clin Rheumatol"},{"key":"633_CR150","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2249.2000.01171.x","volume":"119","author":"C Masson-Bessiere","year":"2000","unstructured":"Masson-Bessiere C et al (2000) In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 119:544\u2013552","journal-title":"Clin Exp Immunol"},{"key":"633_CR151","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","volume":"166","author":"C Masson-Bessiere","year":"2001","unstructured":"Masson-Bessiere C et al (2001) The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 166:4177\u20134184","journal-title":"J Immunol"},{"key":"633_CR152","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0","volume":"44","author":"CC Reparon-Schuijt","year":"2001","unstructured":"Reparon-Schuijt CC et al (2001) Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 44:41\u201347","journal-title":"Arthritis Rheum"},{"key":"633_CR153","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200535790","volume":"36","author":"M Sebbag","year":"2006","unstructured":"Sebbag M et al (2006) Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 36:2250\u20132263","journal-title":"Eur J Immunol"},{"key":"633_CR154","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/kei023","volume":"44","author":"X Chang","year":"2005","unstructured":"Chang X et al (2005) Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology (Oxford) 44:1374\u20131382","journal-title":"Rheumatology (Oxford)"},{"key":"633_CR155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/ar1184","volume":"6","author":"ER Vossenaar","year":"2004","unstructured":"Vossenaar ER, van Venrooij WJ (2004) Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis. Arthritis Res Ther 6:107\u2013111","journal-title":"Arthritis Res Ther"},{"key":"633_CR156","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1443.013","volume":"1143","author":"WJ Venrooij van","year":"2008","unstructured":"van Venrooij WJ et al (2008) Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis. Ann N Y Acad Sci 1143:268\u2013285","journal-title":"Ann N Y Acad Sci"},{"key":"633_CR157","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.4049\/jimmunol.175.9.5575","volume":"175","author":"F Gaalen van","year":"2005","unstructured":"van Gaalen F et al (2005) The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis. J Immunol 175:5575\u20135580","journal-title":"J Immunol"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-017-0633-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-017-0633-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-017-0633-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T04:02:22Z","timestamp":1719201742000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-017-0633-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":157,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1007\/s00281-017-0633-1","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]}}}